245 related articles for article (PubMed ID: 21222046)
1. Tetherin and its viral antagonists.
Kuhl BD; Cheng V; Wainberg MA; Liang C
J Neuroimmune Pharmacol; 2011 Jun; 6(2):188-201. PubMed ID: 21222046
[TBL] [Abstract][Full Text] [Related]
2. BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor.
Swiecki M; Omattage NS; Brett TJ
Mol Immunol; 2013 Jun; 54(2):132-9. PubMed ID: 23274150
[TBL] [Abstract][Full Text] [Related]
3. Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST-2/Tetherin: Knowledge and Gaps.
Berry KN; Kober DL; Su A; Brett TJ
Bioessays; 2018 Oct; 40(10):e1800086. PubMed ID: 30113067
[TBL] [Abstract][Full Text] [Related]
4. Influenza virus partially counteracts restriction imposed by tetherin/BST-2.
Mangeat B; Cavagliotti L; Lehmann M; Gers-Huber G; Kaur I; Thomas Y; Kaiser L; Piguet V
J Biol Chem; 2012 Jun; 287(26):22015-29. PubMed ID: 22493439
[TBL] [Abstract][Full Text] [Related]
5. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction.
Le Tortorec A; Willey S; Neil SJ
Viruses; 2011 May; 3(5):520-40. PubMed ID: 21994744
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of HIV-1 virion entrapment by tetherin.
Venkatesh S; Bieniasz PD
PLoS Pathog; 2013; 9(7):e1003483. PubMed ID: 23874200
[TBL] [Abstract][Full Text] [Related]
8. Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses.
Sakuma T; Sakurai A; Yasuda J
PLoS One; 2009 Sep; 4(9):e6934. PubMed ID: 19742323
[TBL] [Abstract][Full Text] [Related]
9. β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.
Tervo HM; Homann S; Ambiel I; Fritz JV; Fackler OT; Keppler OT
Retrovirology; 2011 Feb; 8():9. PubMed ID: 21310048
[TBL] [Abstract][Full Text] [Related]
10. Human parainfluenza virus type 2 V protein inhibits and antagonizes tetherin.
Ohta K; Goto H; Yumine N; Nishio M
J Gen Virol; 2016 Mar; 97(3):561-570. PubMed ID: 26675672
[TBL] [Abstract][Full Text] [Related]
11. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.
Fitzpatrick K; Skasko M; Deerinck TJ; Crum J; Ellisman MH; Guatelli J
PLoS Pathog; 2010 Mar; 6(3):e1000701. PubMed ID: 20221443
[TBL] [Abstract][Full Text] [Related]
12. Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction.
Lehmann M; Rocha S; Mangeat B; Blanchet F; Uji-I H; Hofkens J; Piguet V
PLoS Pathog; 2011 Dec; 7(12):e1002456. PubMed ID: 22194693
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of the host restriction factor tetherin in viral immune sensing.
Hotter D; Sauter D; Kirchhoff F
J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity.
Zenner HL; Mauricio R; Banting G; Crump CM
J Virol; 2013 Dec; 87(24):13115-23. PubMed ID: 24067977
[TBL] [Abstract][Full Text] [Related]
15. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
[TBL] [Abstract][Full Text] [Related]
16. Tetherin/BST-2: Restriction Factor or Immunomodulator?
Li SX; Barrett BS; Guo K; Santiago ML
Curr HIV Res; 2016; 14(3):235-46. PubMed ID: 26957198
[TBL] [Abstract][Full Text] [Related]
17. The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?
Andrew A; Strebel K
J Interferon Cytokine Res; 2011 Jan; 31(1):137-44. PubMed ID: 21166593
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of the antiviral activity of feline Tetherin/BST-2.
Fukuma A; Abe M; Morikawa Y; Miyazawa T; Yasuda J
PLoS One; 2011 Mar; 6(3):e18247. PubMed ID: 21479233
[TBL] [Abstract][Full Text] [Related]
19. Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells.
Jolly C; Booth NJ; Neil SJ
J Virol; 2010 Dec; 84(23):12185-99. PubMed ID: 20861257
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.
Fritz JV; Tibroni N; Keppler OT; Fackler OT
Virology; 2012 Mar; 424(1):33-44. PubMed ID: 22222210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
